Diacylglycerol kinase (DGK) attenuates levels of second messenger diacylglycerol in cells and produces another (putative) messenger, phosphatidic acid. We have previously purified a 110-kDa DGK from rat brain (Kato, M., and Takenawa, T. (1990) J. Biol. Chem. 265, 794 -800). Here we report the cDNA cloning from human brain and retina cDNA libraries. The cDNA encodes a novel DGK isotype, termed DGK, of 941 amino acids with an apparent molecular mass of 110 kDa. DGK contains a C-terminal putative catalytic domain, which is present in all eukaryotic DGKs. In contrast to other DGK isotypes, DGK contains three cysteine-rich domains instead of two. The third cysteine-rich domain is most homologous to the second one in other DGK isotypes. This particular sequence homology extends C-terminally beyond the typical cysteine/histidine core structure and is DGKspecific. DGK furthermore contains various domains for protein-protein interaction, such as a proline-and glycine-rich domain with a putative SH3 domain-binding site and a pleckstrin homology domain with an overlapping Ras-associating domain. DGK is expressed in the brain and, to a lesser extent, in the small intestine, duodenum, and liver. In situ hybridization of DGK mRNA in adult rat brain reveals high expression in the cerebellar cortex and hippocampus. DGK activity in COS cell lysates is optimal toward diacylglycerols containing an unsaturated fatty acid at the sn-2 position.
addition, the product of DGK (PA) may play a second messenger role as well (3, 5, 6) . PA has been shown to activate a number of enzymes involved in signal transduction, including PKC-(7), unidentified protein kinases (8, 9) , phospholipase C-␥1 (10) , and polyphosphoinositide kinases (11, 12) , in vitro. Furthermore, PA binds to and may regulate the translocation and subsequent activation of the protein kinase Raf-1 (13) and the protein-tyrosine phosphatase PTP1C (14) .
Various isotypes of mammalian DGK have been identified and show their own remarkably cell-specific expression patterns among a wide variety of cell types. The first group of highly homologous isozymes that has been cloned, DGK␣ (15) (16) (17) , DGK␤ (18) , and DGK␥ (19, 20) (also named DGK-I, -II, and -III, respectively), has an apparent molecular mass in the 80 -90-kDa range. These DGKs are characterized by a conserved N-terminal domain of unknown function and EF-hands that bind Ca 2ϩ (2) . A C-terminal (putative) catalytic domain and two cysteine-rich (or zinc-finger) domains (CRDs) are common to all DGKs cloned thus far. A recently characterized 64-kDa isotype, DGK⑀, lacks EF-hands, but is otherwise structurally similar to the first group of DGKs and is highly selective for arachidonate-containing substrates (21) . Two other recently cloned isozymes, DGK␦ and DGK (130 -140 kDa), contain a pleckstrin homology domain (PH domain) near the N terminus (22, 23) . Finally, DGK (also named DGK-IV; 104 kDa) is characterized by four tandem ankyrin-like repeats near the C terminus (24, 25) , a nuclear targeting motif (25) , and a region that is homologous to the phosphorylation site of the MARCKS (myristoylated alanine-rich C kinase substrate) protein (24) . The sequence of DGK closely resembles that of the eye-specific DGK2 from Drosophila encoded by the RgdA gene (26) . A RgdA mutation inactivates DGK2 and causes retinal degeneration, illustrating the essential role of DGK in neurologic functions.
Here we report the molecular cloning of a new isozyme, named DGK, with several unique and interesting structural features. It contains three instead of two CRDs and a PH domain at a different location than in DGK␦ and DGK. The first half of this PH domain overlaps a recently identified putative Ras-binding site, the so-called Ras-associating domain (RA domain) (27) . DGK furthermore contains a proline-and glycine-rich domain at the N terminus, but lacks EF-hands. Each of these conserved domains is typically contained in signaling molecules and is thought to mediate lipid-protein or protein-protein interaction in signal-transducing complexes. The structural properties of this novel DGK and its tissue distribution are presented here in the context of what is known about other DGK isotypes.
EXPERIMENTAL PROCEDURES
Materials-Radiolabeled nucleotides, Hybond-N nylon membranes, and enhanced chemiluminescence (ECL) reagents were from Amersham Corp. Acrylamide was from Serva. ATP, restriction enzymes, T4 DNA ligase, and Klenow enzyme were from Boehringer Mannheim. Taq polymerase was from Life Technologies, Inc. Lipids were from Sigma. T7 DNA polymerase and oligonucleotide primers were from Pharmacia Biotech Inc.
cDNA Cloning and Sequencing-The peptides ATPVQVDGEP-WIQAPGH and EIRLQVEQQEVELPSIEGL were obtained from purified 110-kDa DGK protein (see "Results") through digestion with lysyl endopeptidase and fractionation by C 18 reverse-phase high pressure liquid chromatography with a 0 -60% gradient of acetonitrile in 0.1% trifluoroacetic acid. From these peptides, we derived the respective synthetic oligonucleotides GCCACCCCTGTGCAGGTGGATGG(A/G)-GAGCCCTGGATCCAGGCCCCTGGCCAC and GAGATCAGATTAC-AGGTGGAACAGCAGGAGGTGGAGTTACCCTCGATAGAGGGCTTA as probes to screen a gt10 random-primed cDNA library from rat brain according to standard protocols (28) . From the resulting 2-kb positive clone, a 400-bp PstI fragment was used for further screening of human cDNA libraries (see "Results"). For sequencing, increasing nested deletions were made using the double-stranded nested deletion kit (Pharmacia). Nucleotide sequencing was done by the dideoxy chain termination method (29) as well as automatically on a Model 373 DNA Sequencer (ABI Advanced Biotechnologies, Inc.). Sequence data were analyzed using Genetics Computer Group software (30) .
Reverse Transcriptase Polymerase Chain Reaction (PCR)-Total RNA was isolated from rat tissues using the LiCl method (28) . RNA (10 g) was incubated with random hexamers (50 M final concentration) and annealed for 5 min at 65°C, followed by 10 min at room temperature. cDNA synthesis was performed for 1 h at 37°C in a 20-l reaction mixture containing 50 mM KCl, 10 mM Tris-HCl (pH 8.3), 1.5 mM MgCl 2 , 0.01% gelatin, 1 mM dNTPs, 2 units/ml RNase inhibitor, and 10 units of reverse transcriptase (SuperScript, Life Technologies, Inc.). After inactivation (5 min at 90°C), the reaction mixture was diluted 5-fold, and 5 l of this diluted mixture was used for PCR amplification. PCR was done in the presence of two rat DGK-specific primers or two glyceraldehyde-phosphate dehydrogenase-specific primers as a control. PCR was carried out for 25 cycles as follows: 94°C for 1 min, 55°C for 1 min, and 72°C for 1 min, followed by a final elongation step for 10 min at 72°C. One-tenth of the PCR product was subsequently separated on an agarose gel, transferred to Hybond-N nylon membrane, and hybridized with a rat cDNA probe.
Antibody-A mouse anti-DGK monoclonal antibody was made against an Escherichia coli cell-expressed, affinity-purified glutathione S-transferase fusion protein of a C-terminal portion (part of the catalytic domain) of rat DGK. To this end, a 1.7-kb PstI-EcoRI fragment of the rat cDNA clone was subcloned into pGEX3X vector.
In Situ Hybridization Histochemistry-Fresh frozen blocks of brain from adult male rats were sectioned at 30-m thickness on a cryostat. The sections were mounted on silane-coated glass slides and immersed in 4% paraformaldehyde and 0.1 M phosphate buffer (pH 7.2) for 20 min, followed by acetylation in 0.25% acetic anhydride in 0.1 M triethanolamine. The slides were prehybridized in a fluid containing 50% formamide, 4 ϫ SSC, 1 ϫ Denhardt's solution, 1% sarcosyl, 0.1 M sodium phosphate buffer (pH 7.2), 100 mM dithiothreitol, and 200 g/ml heatdenatured salmon sperm DNA for 2 h at room temperature. Hybridization was in the same solution containing 10% dextran sulfate and 1 ϫ 10 6 cpm/slide of 35 S-dATP-labeled cDNA probe at 42°C for 16 h in a moist chamber. The probe corresponded to the 3Ј-noncoding region of the rat DGK sequence (HindIII-EcoRI fragment, 800 bp). After hybridization, the slides were sequentially rinsed in 2 ϫ SSC and 0.1% sarcosyl at 45°C for 30 min and three times in 0.1 ϫ SSC and 0.1% sarcosyl at 45°C for 40 min each and dehydrated in 70 and 100% ethanol. After exposure to Hyperfilm-␤max (Amersham Corp.) for 3 weeks, the sections were dipped in NTB2 emulsion (Eastman Kodak Co.) and exposed for 2 months.
DGK Assay-Cell lysates were made by brief sonication in a medium containing 0.25 M sucrose, 50 mM Hepes (pH 7.4), and protease inhibitors, followed by centrifugation (10 min at 15,000 ϫ g). Lysate samples of 30 l were incubated in an assay mixture (total of 120 l) containing 50 mM Tris-HCl (pH 7.5), 10 mM NaF, 10 mM MgCl 2 , 1 mM dithiothreitol, 1 mM phosphatidylserine, 1 mM deoxycholate, and 1 mM DG or ceramide as substrate. The reaction (10 min at 30°C) was started by the addition of [␥-32 P]ATP (2 mM, 3 Ci) and terminated by thoroughly mixing 100 l of assay mixture with 3.7 ml of methanol, chloroform, and 2 M NaCl (2:1:0.7, v/v/v). After the addition of 1 ml of chloroform and 1 ml of 2 M NaCl and phase separation, radiolabeled reaction product (PA or ceramide 1-phosphate) in the chloroform phase was separated by TLC (Silica Gel 60 plates, Merck) with ethyl acetate/isooctane/acetic acid/H 2 O (13:2:3:10, v/v/v/v) as developing solvent (two runs), scraped off, and quantitated by liquid scintillation counting.
Other Methods-COS-7 cells were transfected using the calcium phosphate precipitation method (31) . SDS-polyacrylamide gel electrophoresis was performed with 8% acrylamide gels (32) . Protein concentration was determined by the Bradford assay (33).
RESULTS
Isolation of cDNA Clones-We have previously purified a 110-kDa DGK protein from rat brain cytosol (34) . To clone the corresponding cDNA, 100 g of this protein was applied to a preparative SDS-polyacrylamide gel and transferred to nitrocellulose membrane. The 110-kDa region was cut out and digested with lysyl endopeptidase, and some of the generated peptides were sequenced (see "Experimental Procedures"). Based on the amino acid sequences, oligonucleotide probes were designed to screen a gt10 rat brain cDNA library. A 2-kb positive clone was isolated. Sequence analysis showed a single open reading frame of 965 bp containing a stop codon, but no start codon. Three of the sequenced peptides were localized, and comparison with other DGKs revealed that this clone encoded part of the putative catalytic domain. We used a 400-bp 5Ј-PstI fragment of this 2-kb rat cDNA to screen a human fetal brain cDNA library. Four positive clones of 1.2, 3, 5, and 6 kb were isolated (Fig. 1) . From restriction enzyme analysis, it appeared that they represented four overlapping cDNAs. Sequencing of these human clones revealed an open reading frame of 2646 bp encoding 882 amino acids with a sequence 90% identical to that of the rat homologue (data not shown). Since the start codon was lacking, we continued by screening a human retina cDNA library using a 1.7-kb EcoRI-KpnI fragment from the partial human DGK cDNA as a probe (Fig. 1 ). An additional 1.4-kb cDNA clone was isolated that overlapped the already obtained sequence, extending to the 5Ј-end and containing a putative ATG start codon. The composite fulllength cDNA and its deduced amino acid sequence are shown in Fig. 2 .
Sequence Analysis-The nucleotide sequence contains an ATG/methionine start codon (CGGGAATGG) that conforms reasonably to the Kozak consensus sequence (CCA/GCCATGG) for efficient initiation of translation (35) . Downstream of this initiation codon is a single open reading frame of 2823 bp. The encoded protein, named DGK, is a new member of the DGK family. It has a calculated molecular mass of 101.3 kDa, close to the apparent size of 110 kDa found for the purified protein (34) . Fig. 3A schematically shows the types and positions of conserved domains in DGK compared with a few other representative DGKs. DGK has a putative catalytic domain similar to all other known DGK isotypes, but does not have the N-terminal conserved domain and EF-hand (Ca 2ϩ -binding) motifs that are present in the classical isozymes DGK␣, -␤, and -␥. DGK has a proline-and glycine-rich region at the N terminus. It also contains a recently identified putative Ras-binding site, the so-called RA domain (Val 397 -Val 488 ) (27), 2 which partially overlaps a PH domain (Lys 399 -Arg 564 ). Fig. 3B shows the amino acid sequence of the PH domain of DGK aligned with those of a few other proteins including DGK␦ (22) as well as with the published PH consensus sequence based on 71 different PH domains (36) . Seven of the eight most conserved, almost completely identical (hydrophobic) residues (marked by asterisks in Fig. 3B ) are indeed present in the DGK PH domain. The eighth one, a tryptophan in block 6B, is replaced in DGK by a similar residue, tyrosine (Fig. 3B) . The overall identity/similar-ity of residues in the six blocks of the PH domain of DGK to those in the consensus sequence amounts to 23/46%, respectively.
A unique structural feature of DGK is the presence of three CRDs (zinc fingers), starting at amino acids 60, 121, and 183, respectively (Figs. 2 and 3C ). All other known DGK isotypes contain only two CRDs. Close inspection of the individual CRDs reveals that the third CRD (CRD3) of DGK is most homologous to the second one (CRD2) of DGK␣ and DGK␦ (Fig.  3C ) and other known DGK isotypes. The amino acid sequence of this domain, apart from its typical core structure (HXWX 10 CX 2 CX 14 CX 2 CX 4 HX 2 CX 7 C), contains an additional 13 conserved amino acids, 11 of which (marked by asterisks in Fig. 3C ) are specifically present in the CRD2 domains of all known DGK isotypes (15) (16) (17) (18) (19) (20) (21) (22) (23) (24) (25) (26) . Interestingly, six of these conserved residues extend the core structure in the C-terminal direction (Fig. 3, A and C) . Klauck et al. (23) already described that the end of CRD2 in previously cloned DGKs is defined by GX 7 PP, but we note that there is actually much more homology and DGK specificity in CRD2 (or DGK CRD3) (Fig. 3C ). CRD1 and CRD2 of DGK, on the other hand, do not at all show such DGK specificity. Although they have additional conserved amino acids next to the cysteine/histidine core structure, they share most of these conserved residues with other CRD-containing molecules, such as PKC (39) and Raf-1 (40) . The homology between DGK CRD2 and CRD3, apart from the typical cysteine/histidine core structure, is relatively low. CRD2 shows higher homology to CRD1.
Another conspicuous and novel feature of DGK is the proline-and glycine-rich region near the N terminus (Figs. 2 and  3A) . It contains 11 glycines (34%) and 9 prolines (28%) over a stretch of 32 amino acids. The first part of this region contains a pXPXXP motif (amino acids 18 -23) , typical for SH3 domainbinding sites (41), and is followed by a proline-glycine tandem repeat (amino acids [37] [38] [39] [40] [41] [42] [43] [44] [45] , the function of which is undefined.
Tissue Distribution of DGK mRNA-The expression of DGK in rat tissues was determined at the mRNA level by reverse transcriptase PCR. Fig. 4 shows that DGK is expressed in the brain and, to a lesser extent, in the small intestine, duodenum, and liver.
In situ hybridization histochemical analysis in adult rat brain reveals that mRNA for DGK is expressed more or less in all the gray matter regions, but not in white matter (Fig. 5A) . Expression is most intense in the cerebellar cortex and hippocampus, while moderate expression is seen in the olfactory bulb neuronal layers and brain stem nuclei. In the cerebellar cortex, the hybridization signals are deposited equally in both the Purkinje cell somata and the granule cells at the same intensity (Fig. 5, B and C) . In control experiments in which brain sections were hybridized with the plasmid vector of an appropriate length, no significant hybridization signals were detected in any brain sections (data not shown).
Expression of DGK in COS Cells and Its Enzymatic
Activity-To test whether the cloned DGK cDNA indeed encodes a DGK, the protein was transiently expressed in COS cells by cDNA transfection. Proper expression was confirmed by Western blotting using a DGK-directed monoclonal antibody (Fig.  6) . The antibody detected a protein of the correct size (110 kDa), indicating that the putative ATG start codon present in the DGK cDNA is indeed used as a translation start codon. The antibody cross-reacted with overexpressed 86-kDa DGK␣ that was used as a positive control. A lysate of vector-transfected cells (control) showed no immunoreactivity (Fig. 6) .
DGK activity was subsequently assayed in the respective COS cell lysates. Table I shows that the expressed DGK is indeed active as a DGK. Similar to DGK␣, the new DGK exhibits the highest activity toward 1,2-dioleoyl-sn-glycerol and 1-stearoyl-2-arachidonoyl-sn-glycerol. In contrast, ceramide, 1,3-dioleoyl-sn-glycerol, and monoacylglycerol are relatively poor substrates.
DISCUSSION
With the molecular cloning of DGK, we add a new member to the growing family of DGKs (15) (16) (17) (18) (19) (20) (21) (22) (23) (24) (25) (26) . DGK is structurally different from the previously characterized DGK isotypes and contains unique features, such as three (instead of two) CRDs, a proline-and glycine-rich region, and a recently identified RA domain (27) . No other DGK isotype, except a putative DGK in Caenorhabditis elegans (42) , contains such an RA domain (27) . This implies that DGK is a potential new effector of one or more of the Ras-like small GTP-binding proteins. The RA domain is located within a PH domain. DGK␦ (22) and DGK (23) FIG. 1. Cloning strategy of human DGK. Thick lines denote the cDNA clones isolated (i.e. 2 kb from rat brain; 1.2, 3, 5, and 6 kb from human fetal brain; and 1.4 kb from human retina). Arrows indicate the extent and direction of sequencing of the different clones. To obtain the full-length human DGK cDNA, a human fetal brain cDNA library was first screened using the indicated PstI-PstI probe. Subsequently, a human retina cDNA library was screened using the indicated human EcoRI-KpnI probe. A schematic representation of the full-length DGK primary structure is given, showing its prominent domains. PR, proline-and glycine-rich domain; Cat, catalytic domain. also possess a PH domain, but it is differently (centrally) located in the molecule and is without an RA domain. The finding that a Ras-binding site coincides with another functional domain is not unique. In Raf-1, for example, a Ras-binding site (different from the RA domain) has been detected in its CRD (43) . Analogous to this Raf-1 CRD, the PH/RA region in DGK might play a multifunctional role, i.e. binding to a Ras-like small G protein and to another, PH domain-binding molecule. In general, PH domains are believed to function in proteinprotein interactions among cytoskeletal and other signaling molecules (36) . For example, they may interact with ␤␥-complexes of heterotrimeric G proteins (44) and with protein kinase C (45) . In addition, PH domains can bind polyphosphoinositides (46 -49) . All these molecules, involved in signaling, are located in or at the membrane and may thus potentially be involved in proper membrane relocation and subsequent activation of DGK. Enzymatic activity may be further regulated through phosphorylation, e.g. by PKC, as we have previously found for DGK␣ in vivo (50) . DGK contains six potential PKC phosphorylation sites (51) at amino acids 240, 260, 294, 311, 317, and FIG. 2. Nucleotide and deduced amino acid sequences of human DGK cDNA. Amino acids are numbered starting from the first methionine residue. The proline-and glycine-rich domain is indicated in boldface italics. The three CRDs, including a 12-amino acid conserved C-terminal extension of CRD3 (see Fig. 3 (A and C) ), are shaded. The PH domain is underlined. The most conserved residues of the RA domain are indicated in boldface and are shaded. The putative catalytic domain is double-underlined. The stop codon is indicated by an asterisk.
363 in an alanine-and glycine-rich region between CRD3 and the PH domain. It would be interesting to investigate whether DGK activity in cells is regulated by phosphorylation through interaction of its PH domain with an activated PKC, as found for Bruton tyrosine kinase (45) .
The presence of three CRDs is unique to DGK. All other known DGK isotypes contain only two CRDs. In fact, no other protein has been described to contain three such domains. Most PKC isotypes, except the atypical ones, have two CRDs (39), while various other signaling proteins such as Raf isotypes (40, 43) , Vav (52), and n-chimaerin (53) have only one CRD. While CRDs in these proteins are generally thought to mediate protein-protein interaction as well as to bind to acidic phospholipids in membranes (43, 54) , those in the classical and "new" PKCs are also known to bind phorbol ester and DG (54) . However, we found that DGK␣ and DGK do not bind phorbol esters (data not shown).
All CRDs typically contain the Cys 6 /His 2 core structure with defined spacing, which is important for binding of zinc in a tetrahedral geometry (55) . Between these core residues, however, the primary sequence (inter-Cys sequence) varies according to the type of protein. In DGK, the inter-Cys sequence of amino acids (a.a) . PR, proline-and glycine-rich domain; Cat, catalytic domain. B, amino acid sequence of the PH domain of DGK aligned with that of dynamin (37), Tiam-1 (38), and DGK␦ (22) . Identical and similar residues are in black boxes and gray boxes, respectively. Groups of similar amino acids are defined elsewhere (22, 36) . The consensus lists the most frequent residues in the alignment of 71 different PH domain sequences (36) . The most conserved (almost exclusive) residues are marked by asterisks. Conserved blocks are underlined and numbered from 1 to 6. Large nonconserved insertions have been removed, and the number of missing residues is given (n). C, amino acid sequence alignment of the three CRDs of DGK with the two CRDs of human DGK␣ and DGK␦ (16, 22) . The conserved Cys/His core residues are in black boxes, whereas other conserved residues are in gray boxes. CRD3 of DGK and CRD2 of other DGK isotypes (of which only DGK␣ and DGK␦ are shown) (15) (16) (17) (18) (19) (20) (21) (22) (23) contain conserved amino acids (marked by asterisks) that are specific for (this domain of) DGK. Note that this unique conserved region extends 12 amino acids beyond the C-terminal Cys of the CRD core structure. The numbers of the first and last amino acids of the respective domains are indicated. Dashes are amino acid gaps inserted to maximize alignment.
CRD3 is homologous to that of CRD2 in other DGKs, but quite distinct from CRD1 domains and DGK CRD2, which are more homologous to CRDs of PKC (39) and Raf-1 (40) . Most interesting, within the CRD2/DGK CRD3 group, the sequence homology extends 12 amino acids C-terminally beyond the last core cysteine. Together with additional conserved amino acids within the inter-Cys sequence, it makes this structure very typical and specific for DGKs and different from CRDs of PKC (39) and Raf-1 (40) . While the function of the three CRDs in DGK or the two CRDs in DGKs in general is unknown, we found that deletion of the CRDs in DGK␣ inactivates the enzyme. 3 It is therefore tempting to speculate that the CRDs, particularly the "extended" most C-terminal one, are somehow involved in DG binding and/or presentation to the catalytic domain.
The proline-and glycine-rich region near the N terminus of DGK is intriguing. It includes a pXPXXP motif, which is characteristic of SH3 domain-binding proteins (41) . We found this motif also in DGK⑀ (21) and DGK (24) (likewise near the N terminus), but not in other DGKs. Whether DGK, -⑀, andactually bind to SH3 domains of other proteins remains to be demonstrated. A little downstream from this motif, DGK also contains a conspicuous proline-glycine tandem repeat. Data base screening revealed one other protein, a DNA-binding regulatory factor, RFX5 (56), with such a motif. The precise function of this (PG) n domain is unknown. It may induce a loop or turn in the three-dimensional structure of DGK, which is important for proper folding of the molecule, or it might be involved in protein-protein interaction.
The (putative) catalytic domain of DGK is homologous (62%) to that in other DGKs and is contiguous, as in all DGKs except DGK␦ and DGK (22, 23) , where it is separated into two subdomains (Fig. 3A) . Although a protein kinase ATP-binding motif was found in the catalytic domain of several DGK isotypes, such a motif is not present in DGK and DGK␦ (22) . In fact, based on mutational analysis of DGK␣, we have previously argued that the consensus sequence for ATP-binding sites in protein kinases does not apply to DGKs (57) .
The substrate specificity of DGK is not much different from that of most other DGK isotypes. The activity of DGK is FIG. 4 . Tissue distribution of DGK mRNA. Total RNA from different rat tissues was reverse-transcribed to cDNA. One-twentieth of this cDNA product was used in 25 cycles of PCR amplification with two rat DGK-specific primers and two glyceraldehyde-phosphate dehydrogenase (GAPDH)-specific primers as controls. The expected lengths of the DGK and glyceraldehyde-phosphate dehydrogenase products are 850 and 400 bp, respectively. One-tenth of the PCR product was separated on an agarose gel and blotted onto nylon membrane. Amplification products were detected using (16), or the empty pmtSM vector as indicated. Two days later, cells were harvested and lysed. DGK proteins were visualized by Western blotting using a monoclonal antibody against a C-terminal epitope of rat DGK, followed by enhanced chemiluminescence.
TABLE I Activity of DGK isozymes expressed in COS cells
Two days after COS cell transfection with cDNA of human DGK, human DGK␣, or empty vector (pmtSM), cell lysates were assayed for DG kinase activity, as described under "Experimental Procedures," with the substrates indicated. Data are means of duplicates and are representative of three independent experiments. optimal toward DG with an unsaturated fatty acid at the sn-2 position, but is not specific for arachidonoyldiacylglycerol, as has been found for DGKs in the testis (21, 58) . DGK shows a narrow tissue distribution, as do other DGK isotypes except DGK (24) . Expression of DGK mRNA is highest in the brain, as was also found for DGK␣, -␤, -␥, and -, but not for DGK␦ (skeletal muscle) (22) and DGK⑀ (testis) (21) . In situ hybridization revealed the highest DGK mRNA levels in the cerebellum and hippocampus. Compared with DGK␥ (DGK-III), which is also dominantly expressed in the cerebellum, most strongly in Purkinje cells (20) , DGK shows a wider expression in gray matter and a more equal expression in Purkinje and granule cells (Fig. 5) .
Very little is known about the detailed function of DGK in signal transduction. The substantial sequence (domain) diversity among DGK family members, however, suggests their physiological importance and their unique functions in distinct signaling pathways. The finding of several distinct structural and functional domains in DGK may help to discover in which signaling pathway(s) this isozyme operates.
